helixtech.bio

Strategische Führung auf Abruf | HelixTech Leadership & Compliance Strategische Führung auf Abruf Die Brücke zwischen GxP-Compliance und KI-Innovation. In der modernen Biotech-Landschaft reicht ein klassischer CTO oft nicht mehr aus. Sie benötigen eine Doppelkompetenz. Sie benötigen einen erfahrenen Architekten, der sich tiefgehend mit GxP- und HIPAA-Compliance auskennt – aber gleichzeitig einen Fractional CAIO (Chief AI Officer), der sicherstellt, dass Sie keine veraltete Software in einer KI-dominierten Welt bauen. Viele Startups scheitern an diesem Spagat: Sie bauen entweder sicher, aber veraltet – oder innovativ, aber unregulierbar. HelixTech löst dieses Dilemma durch integrierte strategische Führung. Der Mehrwert Keine Experimente auf Kosten d...

The Hostage Situation: Why You Need a Fractional CTO | HelixTech Leadership Strategy The Hostage Situation: Are You Trapped by Your Own Tech Team? You pay the invoices. You own the equity. But you don't call the shots. There is a dynamic killing more Biotech startups than bad science: "The Hostage Situation." It happens when a non-technical CEO depends on a technical team that demands resources but stops delivering value. You feel trapped. You can't fire them because they hold the keys to the code and the cloud. If they leave, the company dies. If they stay, the company bleeds. This power asymmetry creates a paralysis where the business strategy is held captive by technical opacity. You find yourself approving budgets you don't understand, fueled by the "Sunk Cost Fallacy"—...

Navigating Compliance While Unlocking Innovation For over 15 years, the narrative in regulated industries like Pharma, Diagnostics, and Forensics has been the same: "Agile and compliance will never work together." or "The EU AI Act will kill innovation." I've spent two decades proving that wrong. From leading cloud-native COVID platforms processing 300k tests daily to championing "validation-as-code," I've learned that compliance isn't a blocker—it's an engineering challenge waiting to be solved. "Integrity Before Velocity: Real-world data never sleeps, and manual validation can't keep pace. The only way to survive is continuous retraining and auto-auditing." The Failure Mosaic: Why AI Fails in Pharma We've seen the headlines. Theranos failed because of opacity and false claims. Watson Oncology failed because impressive demos didn't match the me...

You bring the vision. We bring the execution. In the fast-paced world of BioTech, the gap between a scientific breakthrough and a market-ready product is often where startups falter. You have the domain expertise and the vision, but building a scalable, compliant, and secure technical product is a different beast entirely. At  HelixTech , we are not a traditional "dev shop" that sells hours. We are your technical co-founders. Our success is tied to yours—getting you funded, getting you traction, and getting you to market. The HelixTech Promise We cut the fat and focus on what truly matters: building only what drives validation, traction, and funding. We take full ownership of product execution so you can focus on the science. 🧬 For Startups: From Idea to Series A We’ve structured our services into a clear journey designed to match your funding stages. Whether you are sketching ideas on a napkin or preparing for a Series A due diligence, we have a dedicated package for you. ...

  In BioTech, the gap between a scientific breakthrough and a market-ready product is where most startups stall. You have the vision, but building a compliant, scalable product is a different battle. "We learned from years of experience in the trenches of BioTech software, and now we are bringing that expertise directly to you." At  HelixTech , we aren't just a dev shop. We act as your  founding product team . We don't sell hours; we sell the traction you need to secure your next round of funding. Your Roadmap to Funding 🔥 Spark (Inception) Get a functional prototype to wow early investors in 12–16 weeks. 🔨 Forge (Pre-Seed) Launch a fully working MVP with embedded compliance and bio-integrations. ⚡️ Drive (Seed) Scale to a commercial-grade product ready for Series A due diligence. We take ownership of the product execution, freeing you to focus on what matters most: your science and your business model. Let's Discuss Your Roadmap